Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma

被引：0
|
作者：
Chen Huang [1 ]
Chenliang Zhang [2 ]
Jiajin Li [1 ]
Yichun Duan [2 ]
Qiulin Tang [3 ]
Feng Bi [2 ]
机构：
[1] West China Hospital,Division of Abdominal Tumor Multimodality Treatment, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology
[2] Sichuan University,Division of Abdominal Tumor Multimodality Treatment
[3] West China Hospital,undefined
[4] Sichuan University,undefined
[5] Sichuan University,undefined
[6] West China Hospital of Sichuan University,undefined
来源：
Cell Biology and Toxicology | / 41卷 / 1期
关键词：
Hepatocellular carcinoma; Sorafenib; P38γ; Autophagy; Cell drug resistance;
D O I：
10.1007/s10565-024-09979-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] RETRACTED: Physcion Synergistically Enhances the Cytotoxicity of Sorafenib in Hepatocellular Carcinoma (Retracted Article)
    Pan, Xiaoping
    Wang, Chen
    Zhang, Ti
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2019, 302 (12): : 2171 - 2177
  • [2] Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma
    Dogan, Erkan
    Aksoy, Sercan
    Arslan, Cagatay
    Dede, Didem S.
    Altundag, Kadri
    MEDICAL ONCOLOGY, 2010, 27 (04) : 1436 - 1437
  • [3] Probable sorafenib-induced reversible encephalopathy in a patient with hepatocellular carcinoma
    Erkan Dogan
    Sercan Aksoy
    Cagatay Arslan
    Didem S. Dede
    Kadri Altundag
    Medical Oncology, 2010, 27 : 1436 - 1437
  • [4] RETRACTION: Physcion Synergistically Enhances the Cytotoxicity of Sorafenib in Hepatocellular Carcinoma (Retraction of Vol 302, Pg 2171, 2019)
    Pan, Xiaoping
    Wang, Chen
    Zhang, Ti
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2020, 303 (11): : 2950 - 2950
  • [5] Targeting FAM134B-mediated reticulophagy activates sorafenib-induced ferroptosis in hepatocellular carcinoma
    Liu, Zhiqian
    Ma, Changlin
    Wang, Qi
    Yang, Hao
    Lu, Zhihua
    Bi, Tao
    Xu, Zongzhen
    Li, Tao
    Zhang, Ling
    Zhang, Yajie
    Liu, Jingfang
    Wei, Xiaoqing
    Li, Jie
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 589 : 247 - 253
  • [6] Resminostat sensitizes hepatocellular carcinoma cells to sorafenib-induced cell death
    Soukupova, J.
    Urricelqui, U. U.
    Borgmann, M.
    Kohlhof, H.
    Fabregat, I.
    EUROPEAN JOURNAL OF CANCER, 2016, 69 : S87 - S87
  • [7] Sorafenib-induced liver failure in a hepatocellular carcinoma patient: Letter to the editor
    Chou, Tsung-Pin
    Hu, Jui-Ting
    Hung, Chih-Sheng
    Chen, Hsin-Yi
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2022, 46 (06)
  • [8] Successful Treatment of Hepatocellular Carcinoma with Regorafenib after Sorafenib-induced Hypersensitivity
    Yoshioka, Naoki
    Kuzuya, Teiji
    Ito, Takanori
    Ishizu, Yoji
    Honda, Takashi
    Ishikawa, Tetsuya
    Ishigami, Masatoshi
    Fujishiro, Mitsuhiro
    INTERNAL MEDICINE, 2019, 58 (19) : 2803 - 2808
  • [9] Sorafenib-induced acute localized exanthematous pustulosis in a patient with hepatocellular carcinoma
    Liang, C. -P.
    Yang, C. -S.
    Shen, J-L.
    Chen, Y. -J.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (02) : 443 - 445
  • [10] Sorafenib-Induced Interstitial Pneumonitis in a Patient with Hepatocellular Carcinoma: A Case Report
    Myung, Hyung-Joon
    Jeong, Sook-Hyang
    Kim, Jin-Wook
    Kim, Hee-Sup
    Jang, Je-Hyuck
    Yoon, Ho Il
    Kim, Jae-Sung
    GUT AND LIVER, 2010, 4 (04) : 543 - 546
12345